Revolution Medicines, Inc. (RVMD)
NASDAQ·Healthcare·Biotechnology
$144.62
+9.92%
Mkt Cap $29.51B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $3.68M | — | — | -$1.58 | -$1.86 | -17.72% | — | — |
| Q4 2025 Nov 5, 2025 | $1.69M | — | — | -$1.42 | -$1.61 | -13.38% | — | — |
| Q3 2025 Aug 6, 2025 | $27.53M | — | — | -$0.94 | -$1.31 | -39.36% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$1.12 | -$1.13 | -0.89% | — | — |
| Q1 2025 Feb 26, 2025 | $346.15K | $261.59M | +75471.86% | -$1.01 | -$1.12 | -10.89% | — | — |
| Q4 2024 Nov 6, 2024 | $346.15K | — | — | -$0.89 | -$0.94 | -5.24% | — | — |
| Q3 2024 Aug 7, 2024 | $750.00K | — | — | -$0.77 | -$0.81 | -5.19% | — | — |
| Q2 2024 May 8, 2024 | $1.37M | — | — | -$0.75 | -$0.70 | +6.21% | — | — |
| Q1 2024 Feb 26, 2024 | $1.09M | $742.00K | -31.93% | -$0.86 | -$1.14 | -32.56% | — | — |
| Q4 2023 Nov 6, 2023 | $670.00K | — | — | -$1.01 | -$0.99 | +1.98% | — | — |
| Q3 2023 Aug 8, 2023 | $1.56M | $3.82M | +145.13% | -$0.83 | -$0.92 | -10.84% | — | — |
| Q2 2023 May 8, 2023 | $2.94M | $7.01M | +138.57% | -$0.84 | -$0.72 | +14.29% | — | — |
| Q1 2023 Feb 27, 2023 | $7.80M | $15.33M | +96.47% | -$0.84 | -$0.63 | +25.00% | — | — |
| Q4 2022 Nov 7, 2022 | $6.34M | $3.36M | -47.04% | -$0.87 | -$0.87 | +0.00% | — | — |
| Q3 2022 Aug 9, 2022 | $7.02M | $9.12M | +29.89% | -$0.87 | -$0.82 | +5.75% | — | — |
| Q2 2022 May 9, 2022 | $8.58M | $7.58M | -11.71% | -$0.82 | -$0.78 | +4.88% | — | — |
| Q1 2022 Feb 28, 2022 | $8.99M | $9.46M | +5.23% | -$0.65 | -$0.71 | -9.23% | — | — |
| Q4 2021 Nov 10, 2021 | $923.42K | $1.10M | +19.23% | -$0.62 | -$0.72 | -16.13% | — | — |
| Q3 2021 Aug 11, 2021 | $8.70M | $8.70M | +0.00% | -$0.55 | -$0.60 | -9.09% | — | — |
| Q2 2021 May 10, 2021 | $9.94M | $10.13M | +1.96% | -$0.52 | -$0.53 | -1.92% | — | — |